Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Repeat administration of AS2034178 enhanced insulin sensitivity in an insulin tolerance test and a euglycemic-hyperinsulinemic clamp test
thereby preventing tumor cell replication
It stimulates the expression of PGC-1α and downstream genes in skeletal muscle cells
GSK269962B
Naloxegol - CAS# 854601-70-0 Catalog No.:M6640-10S Repeat administration of AS2034178 enhancedNaloxegol, CAS No. 854601 70 0, also known as and NKTR 118 and AZ 13337019, is a peripherally selective opioid antagonist for the treatment of opioid induced constipation. It was approved in 2014 in adult patients with chronic, non cancer pain. Chemically, naloxegol is a pegylated (polyethylene glycol modified) derivative of naloxol. Specifically, the 5 hydroxyl group of naloxol is connected via an ether linkage to the free hydroxyl group of a
US$ 46.00
US$ 58.00
US$ 58.00
US$ 73.00
US$ 58.00
US$ 71.00
US$ 61.00
US$ 73.00
US$ 75.00
US$ 61.00
US$ 48.00
US$ 32.00